Mitchell, Jennifer M. http://orcid.org/0000-0002-7567-8129
Bogenschutz, Michael
Lilienstein, Alia
Harrison, Charlotte
Kleiman, Sarah
Parker-Guilbert, Kelly
Ot’alora G., Marcela http://orcid.org/0000-0001-6174-7317
Garas, Wael
Paleos, Casey
Gorman, Ingmar http://orcid.org/0000-0003-4674-2969
Nicholas, Christopher
Mithoefer, Michael
Carlin, Shannon
Poulter, Bruce http://orcid.org/0000-0002-0489-2806
Mithoefer, Ann
Quevedo, Sylvestre
Wells, Gregory http://orcid.org/0000-0003-0902-5282
Klaire, Sukhpreet S.
van der Kolk, Bessel
Tzarfaty, Keren
Amiaz, Revital
Worthy, Ray
Shannon, Scott
Woolley, Joshua D.
Marta, Cole
Gelfand, Yevgeniy
Hapke, Emma
Amar, Simon
Wallach, Yair
Brown, Randall
Hamilton, Scott
Wang, Julie B.
Coker, Allison http://orcid.org/0000-0001-5353-4653
Matthews, Rebecca
de Boer, Alberdina
Yazar-Klosinski, Berra
Emerson, Amy
Doblin, Rick
Funding for this research was provided by:
Multidisciplinary Association for Psychedelic Studies
Article History
Received: 5 February 2021
Accepted: 2 April 2021
First Online: 10 May 2021
Competing interests
: The authors declare the following financial competing interests: A.E., R.M., C.H., A.D.B., S.C., A.C. and J.B.W. received salary support for full-time employment with MAPS PBC for this study and other work; A.L., B.Y.-K. and R.D. received salary support for full-time employment with MAPS for this study and other work; M.M., A.M., M.O.G., B.P. and K.T. received support as contractors from MAPS PBC for training and supervision of research psychotherapists for this study and other work; S.K., K.P.-G. and S.H. received support as contractors of MAPS PBC for their contributions to this study and other work; and study investigators and researchers, J.M.M., M.B., M.O.G., W.G., C.P., I.G., C.N., B.P., S.Q., G.W., S.S.K., B.V.D.K., K.T., R.A., R.W., S.S., J.D.W., C.M., Y.G., E.H., S.A., Y.W. and R.B., received funding from MAPS PBC during the conduct of the study for this study as well as other studies. The following authors disclose receipt of personal fees or grants from companies in the field, but unrelated to the present work: M.B. (Heffter Research Institute, Turnbull Family Foundation, B. More, Mind Medicine, Fournier Family Foundation, Bill Linton, George Sarlo Foundation, RiverStyx Foundation, Dr. Bronners Family Foundation, and National Institutes of Health), C.P. (Fluence and Mindbloom), J.D.W. (Filament Ventures and Silo Pharmaceuticals), and J.M.M. and A.C. (Usona Institute). The following authors disclose non-financial relationships with organizations in the field: M.M. and A.M. serve on the Scientific Advisory Board for Awaken Life Sciences, C.P. co-founded Nautilus Sanctuary and Nautilus Psychiatric Services, S.S. serves on the advisory board for Maya Health, and I.G. serves on the Scientific Advisory Board of Journey Clinical and co-founded Fluence.